Ross Cagan
regius chair of precision Medicine and dean of Innovation University of Glasgow
After a Ph.D. from Princeton University and a postdoc at UCLA, he became a Professor at Washington University School of Medicine (1993-2007) and then at the Icahn School of Medicine at Mount Sinai (2007-2020). He is currently Regius Professor of Precision Medicine and Royal Society Wohl Fellow at the University of Glasgow and Scientific Director of the Wolfson Wohl Cancer Research Centre. He was a co-founder of the biotechnology company Medros Inc. His lab developed highly complex, whole-animal models for cancer and inherited genetic diseases, and this work contributed to the first FDA-approved chemotherapeutic for Medullary Thyroid Carcinoma. With chemist Arvin Dar and computational chemist Avner Schlessinger, his lab developed a platform that combines genetics with medicinal and computational chemistry to build novel lead compounds that emphasize rational polypharmacology. He leads a team that treats thyroid and colorectal cancer patients through a personalized fly-to-bedside, open-label clinical trial.
Past talks
Sat. 26 September
at 16:30 - 17:45
16:30 - 17:45
Saturday 26 September
Sala Predonzani
Ingresso via dell’Orologio 1, Trieste, TS
Ingresso via dell’Orologio 1, Trieste, TS
TRIESTE
Intelligence emerges across biological scales, from the adaptive behaviour of cells to the complex dynamics of neural circuits and whole organisms. We explore how “intelligence” manifests in health and disease, bringing together molecular pathology and neurodegenerative disease research. The panel examines how cells sense and respond to stress, how neural systems adapt or fail in ALS, and how this informs new therapeutic strategies. Connecting fundamental biology with clinical challenges and broader societal implications, the event aims to deepen public understanding and encourage dialogue.
Intervengono
Location: Sala Predonzani - Ingresso via dell’Orologio 1, Trieste
speakers
